SS
SUPN icon

Sunbelt Securities’s Supernus Pharmaceuticals SUPN Stock Holding History

Sunbelt Securities’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.7K Hold
304
– – ﹤0.01% 1361
2025
Q4 		$15.1K Hold
304
– – ﹤0.01% 1332
2025
Q3 		$14.5K Buy
304
+16
+6% +$644 ﹤0.01% 1350
2025
Q2 		$10.4K Hold
288
– – ﹤0.01% 1297
2025
Q1 		$9.43K Hold
288
– – ﹤0.01% 1289
2024
Q4 		$10.6K Hold
288
– – ﹤0.01% 1298
2024
Q3 		$8.98K Hold
288
– – ﹤0.01% 1308
2024
Q2 		$7.7K Hold
288
– – ﹤0.01% 1317
2024
Q1 		$9.82K Buy
+288
New +$8.57K ﹤0.01% 1247
2023
Q4 		– Sell
-35
Closed -$965 – 1782
2023
Q3 		$965 Buy
+35
New +$1.06K ﹤0.01% 1594

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sunbelt Securities's SUPN Position: Q1 2026 in Review

Sunbelt Securities held its Supernus Pharmaceuticals (SUPN) position steady in Q1 2026 at 304 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1361.

Sunbelt Securities first reported a position in SUPN in Q3 2023 and has held it in 10 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Sunbelt Securities held 304 shares of Supernus Pharmaceuticals worth $15.7K as of Q1 2026.
  • Sunbelt Securities left its Supernus Pharmaceuticals share count unchanged in Q1 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1361 holding.
  • Sunbelt Securities first reported a position in Supernus Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.